Azitra
AZTR
Azitra (AZTR) news
Recent news
Azitra, Inc. advances ATR-04 phase 1/2 clinical trial to cohort 2 following safety review committee clearance
AInvest Wire · Oct 1, 2026Azitra - Enters sales agreement with A.G.P. for common stock offering - SEC filing
AInvest Wire · Sep 28, 2026Azitra, Inc. regains compliance with NYSE American continued listing standards
AInvest Wire · Aug 21, 2026Azitra - to pause further enrollment in ATR-12 trial to redirect funds to ATR-COSF
Azitra Inc. has announced a strategic shift in its clinical development priorities, pausing further enrollment in its ATR-12 trial to redirect resources toward its ATR-COSF program . The decision follows a comprehensive review of the company’s research portfolio and an assessment of the potential…
AInvest Wire · Jun 17, 2026Azitra, Inc. CEO issues letter to shareholders detailing strategic reorientation initiatives and outlook for 2026 and beyond
AInvest Wire · Jun 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.